Integrating Quality, Risk, and EHS in the Life Sciences Industry
Because of the industry’s close relation to consumer health and well-being, organizations competing in life sciences have a unique set of hurdles around quality, risk, and Environment, Health, and Safety (EH&S).
Because of the industry’s close relation to consumer health and well-being, organizations competing in life sciences have a unique set of hurdles around quality, risk, and Environment, Health, and Safety (EH&S). Many organizations today are faced with the challenge of disparate enterprise solutions and the resulting inability to communicate and collaborate on a unified information management system. This LNS Research Spotlight will help executives on the quality journey understand the framework for building this holistic quality platform, empowering them to strengthen their existing strategies. Get an overview of the life sciences industry as EtQ goes over benchmark data, the importance of building closed-loop quality processes and how to develop a unified information management system with Enterprise Quality Management Software.
Read more about integrating quality, risk, and EHS in the life sciences industry.
Contact:info@etq.com
Diving Deep into Carrier-Based Formulation and Process Optimization
December 23rd 2024Carrier-based formulations for dry powder inhalers are carefully designed to transport extremely small particles into the lungs. Jet milling can be used to micronize these particles, with both high and low shear mixing processes used to formulate mixtures capable of carrying the fine API particles into the deep lung. This paper looks at the requirements for pulmonary delivery via carrier-based inhaled powder formulations, and how jet milling can be used to manufacture effective and stable materials for these formulations
Molecular Properties of PROTACs and the Relationship to Formulation Design
December 20th 2024Analyzation of a diverse set of PROTAC (Proteolysis Targeting Chimeras – a class of TPDs) structures and their calculated properties, identifying key structure-property trends that contribute to low oral bioavailability.
